Medtronic Signs Zero Health Gaps Pledge To Advance Health Equity

NORTHAMPTON, MA / ACCESSWIRE / January 19, 2023 / Medtronic, From closing health gaps in Kenya with Medtronic LABS, to helping health systems in the U.S. advance access to quality care for underserved patients, Medtronic is committed to advancing health equity. Addressing health equity is critical because more than half the world's population lacks access to essential healthcare. And the most challenging health issues disproportionately impact marginalized populations. But we recognize that no one solution or organization can achieve health equity alone; strategic partnerships are essential to accelerating this critical work.

To maximize its commitment to health equity, Medtronic is joining the Global Health Equity Network (GHEN). GHEN is a World Economic Forum initiative that brings the private and public sectors together to drive change in health equity - mobilizing CEOs and business leaders to prioritize action in organizational strategy and purpose.

As part of the GHEN agenda, Medtronic has signed the Zero Health Gaps Pledge, which provides 10 areas where committed organizations agree to help drive progress within health equity across their workforce, their companies, and in their communities by 2050.

"At Medtronic, we know implementing people-first technology through access-enabling partnerships can be a profound equalizer, helping expand quality care and advance health equity. Leveraging the unique power and assets of our GHEN colleagues, we'll maximize our health equity efforts and collaborate to bring quality healthcare to more people," said Medtronic CEO and Chairman Geoff Martha.

Here are excerpts from three areas within the Zero Health Gaps Pledge, and how Medtronic is bringing them to life:

Pledge: Continually seek to understand how our organization can help address the root causes of health inequities and create a positive health equity impact.

Medtronic LABS develops community-based, tech-enabled solutions with and for underserved patients, reaching over 1M patients to date. An independent nonprofit organization funded by Medtronic, LABS drives system-level transformation to enable scalable, sustainable, last-mile healthcare delivery.

Pledge: Collaborate with communities to identify key health equity needs and identify potential solutions, and to measure impact.

By partnering with local health systems, governments, and NGOs, together we identify gaps in care to build health equity programs. For example, Medtronic established the Health Equity Assistance Program for colon cancer screening to provide GI Genius™ modules to communities with low screening rates or where access to the technology is not currently available.

Pledge: Consistently seek to understand health equity needs across our workforce, consumer base, communities, and ecosystem to make strategic decisions, inclusive of investments, and use insights to inform our organization's choices from strategy to execution.

Financial stability and wealth are inextricably linked to better health outcomes. Medtronic drives economic opportunity by working with small and diverse-owned suppliers, making $2.7 billion in purchases from small and diverse-owned businesses in FY23. And in partnership with the Medtronic Foundation, the company has established several multi-year, multi-million dollar efforts with groups like Thurgood Marshall Fund and Society for Hispanic Professional Engineers to ensure diverse talent has access and opportunity.

Learn more about how our work is impacting communities.

Foto: Accesswire

View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com.

Contact Info:
Spokesperson: Medtronic
Website: https://www.3blmedia.com/profiles/medtronic
Email: [e-mail]

SOURCE: Medtronic

View source version on accesswire.com:
https://www.accesswire.com/735905/Medtronic-Signs-Zero-Health-Gaps-Ple ...


The Medtronic Stock at the time of publication of the news with a fall of -0,93 % to 72,32EUR on Tradegate stock exchange (19. Januar 2023, 14:08 Uhr).

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 81,52$, was einem Rückgang von -2,65% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.

 

Morgan Stanley

 

Alle Partner

Übernehmen

Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche

WerbungDisclaimer